Corcept Therapeutics Incorporated (CORT) short interest & options flow
NASDAQCorcept Therapeutics has shed 30% over the past month and 6.5% in the past week alone, closing at $81.93 on November 3, a move that sits well outside the median weekly change of roughly minus 1.4% for its closest Nasdaq pharmaceutical peers. The gap between where the stock is trading and where analysts think it should trade has rarely been wider, and that tension is the central fact…
CORT cost to borrow surges 184% in one week to 0.40%, signaling rising short pressure despite minimal short interest at 8.1% of float.
- Market cap
- $8.21B
- Next earnings
- 24 Feb 2027
Key data as of 10 Nov 2026
CORT news and analysis
RSSNo long-form analysis yet for CORT. Pulse alerts and the live data picture are available on ORTEX.
Open CORT on ORTEX →Want the live picture for CORT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CORT — free to start on ORTEX.
Sign up for free →Open CORT on ORTEX